Skip to main content
Log in

Significant reduction of sertraline plasma levels by carbamazepine and phenytoin

  • Letter to the Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. MacQueen G, Born L, Steiner M (2001) The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders. CNS Drug Rev 7:1–24

    Article  PubMed  CAS  Google Scholar 

  2. Kobayashi K, Ishizuka T, Shimada N, Yoshimura Y, Kamijia K, Chiba K (1999) Sertraline N-demethylation is catalyzed by multiple isoforms of human cytochrome P-450 in vitro. Drug Metab Dispos 27:763–766

    PubMed  CAS  Google Scholar 

  3. Anderson, GD (1998) A mechanistic approach to antiepileptic drug interactions. Ann Pharmacother 32:554–563

    Article  PubMed  CAS  Google Scholar 

  4. Khan A, Shad MU, Preskorn SH (2000) Lack of sertraline efficacy probably due to an interaction with carbamazepine. J Clin Psychiatry 61:526–527

    Article  PubMed  CAS  Google Scholar 

  5. Markowitz JS, DeVane CL (2000) Rifampicin-induced selective serotonin reuptake inhibitor withdrawal syndrome in a patient treated with sertraline. J Clin Psychopharmacol 20:109–110

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maria Pihlsgaård.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pihlsgaård, M., Eliasson, E. Significant reduction of sertraline plasma levels by carbamazepine and phenytoin. Eur J Clin Pharmacol 57, 915–916 (2002). https://doi.org/10.1007/s00228-001-0416-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-001-0416-3

Keywords

Navigation